Persistence of hemostatic alterations in patients affected by Crohn's disease after bowel surgery

Thrombosis Research

Volumn 87, Issue 6, 1997, Pages 539-546

  Chiarantini, Elena ^a   Valanzano, Rosa ^a   Liotta, Agatina Alessandrello ^b   Cellai, Anna Paola ^b   Ilari, Isabella ^b   Prisco, Domenico ^a   Antonucci, Emilia ^a   Tonelli, Francesco ^a   Abbate, Rosanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Antiphospholipid antibodies; Coagulation; Crohn's disease; Fibrinolysis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; COLITIS; CROHN DISEASE; FEMALE; FIBRINOLYSIS; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; MALE; PRIORITY JOURNAL; THROMBOSIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; COLOSTOMY; CROHN DISEASE; FACTOR XIII; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN INACTIVATORS; PLATELET AGGREGATION; PLATELET COUNT; PROTHROMBIN; SEVERITY OF ILLNESS INDEX;

EID: 0030842989     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00183-7     Document Type: Article

References (30)

1. GLIKMAN R.M. Inflammatory bowel disease: ulcerative colitis and Crohn's disease. In "Harrison's. Principles of internal medicine". KJ Isselbacher, E Braunwald, JD Wilson, JR Martin, AS Fauci, DL Fauci. pp 1403-1417, McGRAW-HILL Inc.(eds), New York 1994.
2. LAM A, BORDA IT, INWOOD MJ, and THOMSON S. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68, 245-25, 1975.
3. TALBOT RW, HEPPEL J, DOZOIS RR, BEART RW Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 61:1986;140-145.
4. EDWARDS RL, LEVINE JB, GREEN R, DUFFY M, MATHEWS E, BRANDE W, RICKLES FR Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology. 92:1987;329-337.
5. KOENIGS KP, Mc PHEDRAN P, SPIRO HM Thrombosis in inflammatory bowel disease. J Clin Gastroenterol. 9:1987;617-621.
6. CONLAN MJ, HAIRE WD, BURNETT DA Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci. 34:1989;1089-1093.
7. DE JONG E, PORTE RJ, KNOT EAR, VERHEIJEN JH, DEES J Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and feces. Gut. 30:1989;188-194.
8. WAKEFIELD A, COHEN Z, LEVY G. Procoagulant activity in gastroenterology. Gut. 31:1990;239-241.
9. VECCHI M, CATTANEO M, DE FRANCHIS R, MANNUCCI PM Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of haemostatic measurements. Int J Clin Lab Res. 21:1991;165-170.
10. HUDSON M, HUTTON RA, WAKEFIELD AJ, SAWYERR AM, and POUNDER RE. Evidence for activation of coagulation in Crohn's disease. Blood Coag Fibrinolysis 3, 7773-778, 1992.
11. WEBBERLEY MJ, HART MD, MELIKIAN V Thromboembolism in inflammatory bowel disease: role of platelets. Gut. 34:1993;247-251.
12. SIMI M, LEARDI S, TEBANO MT, CASTELLI M, COSTANTINI FM, SPERANZA W Raised plasma concentrations of platelet factor 4 (PF 4) in Crohn's disease. Gut. 28:1987;333-338.
13. VIANNA JL, D'CRUZ DP, KHAMASTA MA, ASHERSON RA, HUGHES GR Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin Exp Rheumatol. 10:1992;165-168.
14. REICHT G, PETRITSCH W, WENZL H, EHERER A, HINTERLEITNER TA, AUER-GRUMBACH P, KREJS GJ Increased anticardiolipin antibodies in patients with inflammatory bowel disease. Gastroenterolgy. 104:1993;A768.
15. CHAMOUARD P, GRUNEBAUM L, WIESEL ML, FREYSSINET JM, DUCLOS B, CAZENAVE JP, BAUMANN R Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci. 39:1994;1501-1504.
16. CHIARANTINI E, VALANZANO R, ALESSANDRELLO LIOTTA A, CELLAI AP, FEDI S, ILARI I, PRISCO D, TONELLI F, ABBATE R Haemostatic abnormalities in inflammatory bowel disease. Thromb Res. 82:1996;137-146.
17. BEST WR, BECKTEL JM, SINGELTON JW, KERN F Jr. Development of Crohn's disease activity index. Gastroenterology. 70:1976;439-444.
18. GRAY RP, HENDRA TJ, PATTERSON DLH, YUDKIN JS "Spontaneous" platelet aggregation in whole blood in diabetics survivors of acute myocardial infarction. Thromb Haemost. 70:1993;932-936.
19. ALVING BN, BALDWIN PE, RICHARDS RL, JAKSON BJ The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulant. Thromb Haemost. 54:1985;709-712.
20. EXNER TE, RICKARD KA, KRONBERG H A sensitive test demonstrating Lupus Anticoagulant and its behavioural patterns. Br J Haematol. 40:1978;143-151.
21. THIAGARAJAN P, PENGO V, SHAPIRO SS The use of dilute Russell viper venom time for the diagnosis of Lupus Anticoagulant. Blood. 68:1986;869-874.
22. SCHLEIDER MA, NACHMAN RL, JAFFE EA, COLEMAN M A clinical study of the Lupus Anticoagulant. Blood. 48:1976;499-509.
23. TRIPLETT DA, BRANDT JT, KALZOR D, SCHAFFER J Laboratory diagnosis of Lupus Inhibitors: a comparison of the neutralization procedure. Am J Clin Pathol. 79:1983;678-672.
24. HUDSON M, WAKEFIELD AJ, HUTTON RA, SANKEY EA, DHILLON AP, MORE L, SIM R, POUNDER RE Factor XIII subunit and Crohn's disease. Gut. 34:1993;75-79.
25. SCHAUFELBERGER HD, UHR MR, SMITH AC, LOGAN RPH, GORDAN-SMITH EC, MISIEWICZ JJ Platelet activation in inflammatory bowel disease. Gut. 34:1993;s50. (abstract).
26. COLLINS CE, RAMPTON DS Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut. 36:1995;5-8.
27. CHAMOUARD P, DUCLOS B, BAUMANN R, GRUNEBAUM L, WIESEL ML, FREYSSINET JM, CAZENAVE JP Antiphospholipid antibodies in inflammatory bowel disease; (letter). Dig Dis Sci. 7:1995;1524-1525.
28. RUTGEERTS P, GEBOES K, VANTRAPPEN G, BEILS J, KARREMANS R, HIELE M Predictability of the postoperative course of Crohn's disease. Gastroenterology. 99:1990;956-963.
29. OLAISON G, SMEDH K, SJODAHL R Natural course of Crohn's disease after ileocolic resection: endoscopicaly visualised ileal ulcers preceeding symptoms. Gut. 33:1992;331-335.
30. RUTGEERTS P, HIELE M, GEBOES K, PEETERS M, PENNICKX F, AERTS R, KARREMANS R Controlled trials of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology. 108:1995;1617-1622.